Gujarat cancels Health Point Pharma licence, acts against seven firms in codeine trade probe
Gujarat drug regulators cancelled Health Point Pharma’s drug-sale licence and issued or initiated show-cause notices against seven firms over alleged codeine-stock and record irregularities. Sale of 37,762 Rexton-T syrup bottles valued at ₹83.08 lakh was restricted pending investigation.
What happened
Balaji Pharma · Gujarat drug regulators cancelled Health Point Pharma’s licence and issued notices to seven firms after finding codeine-medicine stock and
Key facts
- 1 drug sale licence cancelled
- 7 firms served or being served show-cause notices
- 37,762 bottles of Rexton-T Syrup seized/restricted
- ₹220 MRP per Rexton-T bottle
- ₹83.08 lakh value of Rexton-T stock
- 57 bottles of R Tuss TD Syrup restricted
- ₹9,006 value of R Tuss TD stock
Why this matters
Any distribution, acquisition or partnership diligence involving controlled-drug portfolios should prioritize licence status, stock-record integrity and exposure to ongoing regulatory investigations.
What to watch
- Formal FIRs, arrests or narcotics-law charges connected to codeine diversion
- Additional licence cancellations, product seizures or statewide inspection directives
- Identification of manufacturers, transporters, pharmacies or interstate buyers in the transaction trail
- Court stays or successful appeals that restore Health Point Pharma's licence or release inventory
- Evidence that restricted stock was legitimately documented versus unaccounted or diverted
- Manufacturer notices on supply suspension, distributor termination or revised controlled-drug policies
- Gujarat drug-control authorities are likely to complete physical stock reconciliation, invoice tracing and buyer verification for the restricted 37,762 Rexton-T bottles.
- Impacted distributors will seek hearings, submit compliance records and may challenge licence cancellation or suspension orders administratively or in court.
- Manufacturers supplying codeine-containing syrups may tighten distributor due diligence, dispatch controls, batch tracking and order limits in Gujarat.
- Retail pharmacies and hospitals may substitute non-codeine cough products if authorized inventory movement remains constrained.
- Investigators may share findings with police, narcotics and interstate drug regulators if evidence suggests diversion beyond record-keeping violations.